Biology Reference
In-Depth Information
Swack NS, Hsiung GD (1982) Natural and experimental simian cytomegalovirus infections at a
primate center. J Med Primatol 11:169-177
Sylwester AW, Mitchell BL, Edgar JB, Taormina C, Pelte C, Ruchti F, Sleath PR, Grabstein KH,
Hosken NA, Kern F, Nelson JA, Picker LJ (2005) Broadly targeted human cytomegalovirus-
specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects.
J Exp Med 202:673-685
Tabiasco J, Rabot M, Aguerre-Girr M, El Costa H, Berrebi A, Parant O, Laskarin G, Juretic K,
Bensussan A, Rukavina D, Le Bouteiller P (2006) Human decidual NK cells: unique pheno-
type and functional properties - a review. Placenta 27 Suppl A:S34-S39
Tarantal AF, Salamat MS, Britt WJ, Luciw PA, Hendrickx AG, Barry PA (1998) Neuropathogenesis
induced by rhesus cytomegalovirus in fetal rhesus monkeys (Macaca mulatta). J Infect Dis
177:446-450
Taylor-Wiedeman J, Sissons JG, Borysiewicz LK, Sinclair JH (1991) Monocytes are a major site
of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol
72:2059-2064
Taylor-Wiedeman J, Sissons P, Sinclair J (1994) Induction of endogenous human cytomegalovirus
gene expression after differentiation of monocytes from healthy carriers. J Virol 68:1597-1604
Taylor PM, Rose ML, Yacoub MH, Pigott R (1992) Induction of vascular adhesion molecules
during rejection of human cardiac allografts. Transplantation 54:451-457
Tomazin R, Boname J, Hegde NR, Lewinsohn DM, Altschuler Y, Jones TR, Cresswell P, Nelson
JA, Riddell SR, Johnson DC (1999) Cytomegalovirus US2 destroys two components of the
MHC class II pathway, preventing recognition by CD4+ T cells. Nat Med 5:1039-1043
Tong CY, Bakran A, Peiris JS, Muir P, Herrington CS (2002) The association of viral infection
and chronic allograft nephropathy with graft dysfunction after renal transplantation.
Transplantation 74:576-578
Torriani FJ, Freeman WR, Macdonald JC, Karavellas MP, Durand DM, Jeffrey DD, Meylan PR,
Schrier RD (2000) CMV retinitis recurs after stopping treatment in virological and immuno-
logical failures of potent antiretroviral therapy. AIDS 14:173-180
Tu W, Potena L, Stepick-Biek P, Liu L, Dionis KY, Luikart H, Fearon WF, Holmes TH, Chin C,
Cooke JP, Valantine HA, Mocarski ES, Lewis DB (2006) T-cell immunity to subclinical
cytomegalovirus infection reduces cardiac allograft disease. Circulation 114:1608-1615
Tumilowicz JJ (1990) Characteristics of human arterial smooth muscle cell cultures infected with
cytomegalovirus. In Vitro Cel Dev Biol 26:1144-1150
Tumilowicz JJ, Gawlik ME, Powell BB, Trentin JJ (1985) Replication of cytomegalovirus in
human arterial smooth muscle cells. J Virol 56:839-845
Valantine HA (2004) The role of viruses in cardiac allograft vasculopathy. Am J Transplant
4:169-177
Valantine HA, Gao SZ, Menon SG, Renlund DG, Hunt SA, Oyer P, Stinson EB, Brown BW Jr,
Merigan TC, Schroeder JS (1999) Impact of prophylactic immediate posttransplant ganciclovir
on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-
controlled study. Circulation 100:61-66
Valchanova RS, Picard-Maureau M, Budt M, Brune W (2006) Murine cytomegalovirus m142 and
m143 are both required to block protein kinase R-mediated shutdown of protein synthesis.
J Virol 80:10181-10190
Van Dam-Mieras MC, Bruggeman CA, Muller AD, Debie WH, Zwaal RF (1987) Induction of
endothelial cell procoagulant activity by cytomegalovirus infection. Thromb Res 47:69-75
Vazquez-Martul E, Mosquera JM, Rivera CF, Hernandez AA, Pertega S (2004) Histological
features with clinical impact in chronic allograft nephropathy: review of 66 cases. Transplant
Proc 36:770-771
Vliegen I, Duijvestijn A, Grauls G, Herngreen S, Bruggeman C, Stassen F (2004) Cytomegalovirus
infection aggravates atherogenesis in apoE knockout mice by both local and systemic immune
activation. Microbes Infect 6:17-24
Vochem M, Hamprecht K, Jahn G, Speer CP (1998) Transmission of cytomegalovirus to preterm
infants through breast milk. Pediatr Infect Dis J 17:53-58
